79 related articles for article (PubMed ID: 23851499)
1. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.
Zhang J; Yang J; Roy SK; Tininini S; Hu J; Bromberg JF; Poli V; Stark GR; Kalvakolanu DV
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9342-7. PubMed ID: 12867595
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of GRIM-19 accelerates radiation-induced osteosarcoma cells apoptosis by p53 stabilization.
Chen W; Liu Q; Fu B; Liu K; Jiang W
Life Sci; 2018 Sep; 208():232-238. PubMed ID: 30005830
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells.
Cermák V; Kosla J; Plachý J; Trejbalová K; Hejnar J; Dvorák M
Cell Mol Life Sci; 2010 Oct; 67(20):3557-68. PubMed ID: 20505979
[TBL] [Abstract][Full Text] [Related]
4. Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidate.
Murray OT; Wong CC; Vrankova K; Rigas B
Int J Oncol; 2014 Feb; 44(2):521-9. PubMed ID: 24284479
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of GRIM-1, a cell-death-associated gene product.
Hofmann ER; Nallar SC; Lin L; D'Cunha J; Lindner DJ; Weihua X; Kalvakolanu DV
J Cell Sci; 2010 Aug; 123(Pt 16):2781-91. PubMed ID: 20663920
[TBL] [Abstract][Full Text] [Related]
6. Proteome-wide analysis of protein abundance and turnover remodelling during oncogenic transformation of human breast epithelial cells.
Ly T; Endo A; Brenes A; Gierlinski M; Afzal V; Pawellek A; Lamond AI
Wellcome Open Res; 2018; 3():51. PubMed ID: 29904729
[No Abstract] [Full Text] [Related]
7. Retraction: Identification and characterization of GRIM-1, a cell-death-associated gene product.
Hofmann ER; Nallar SC; Lin L; D'Cunha J; Lindner DJ; Weihua X; Kalvakolanu DV
J Cell Sci; 2021 Nov; 134(22):. PubMed ID: 34817589
[No Abstract] [Full Text] [Related]
8. Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo.
Wang GM; Ren ZX; Wang PS; Su C; Zhang WX; Liu ZG; Zhang L; Zhao XJ; Chen G
Oncol Rep; 2014 Aug; 32(2):573-80. PubMed ID: 24899100
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.
Huang Y; Yang M; Hu H; Zhao X; Bao L; Huang D; Song L; Li Y
Oncotarget; 2016 Jul; 7(27):41404-41420. PubMed ID: 27167343
[TBL] [Abstract][Full Text] [Related]
10. Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in mice.
Kalakonda S; Nallar SC; Jaber S; Keay SK; Rorke E; Munivenkatappa R; Lindner DJ; Fiskum GM; Kalvakolanu DV
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):E4213-22. PubMed ID: 24145455
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.
Kalakonda S; Nallar SC; Gong P; Lindner DJ; Goldblum SE; Reddy SP; Kalvakolanu DV
Am J Pathol; 2007 Oct; 171(4):1352-68. PubMed ID: 17823279
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.
Nallar SC; Kalakonda S; Lindner DJ; Lorenz RR; Lamarre E; Weihua X; Kalvakolanu DV
J Biol Chem; 2013 Mar; 288(11):7930-7941. PubMed ID: 23386605
[TBL] [Abstract][Full Text] [Related]
13. GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring.
Sun P; Nallar SC; Kalakonda S; Lindner DJ; Martin SS; Kalvakolanu DV
Oncogene; 2009 Mar; 28(10):1339-47. PubMed ID: 19151760
[TBL] [Abstract][Full Text] [Related]
14. GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.
Nallar SC; Kalvakolanu DV
Cytokine Growth Factor Rev; 2017 Feb; 33():1-18. PubMed ID: 27659873
[TBL] [Abstract][Full Text] [Related]
15. GRIM-19 function in cancer development.
Moreira S; Correia M; Soares P; Máximo V
Mitochondrion; 2011 Sep; 11(5):693-9. PubMed ID: 21664299
[TBL] [Abstract][Full Text] [Related]
16. GRIM-19 mutations fail to inhibit v-Src-induced oncogenesis.
Kalakonda S; Nallar SC; Lindner DJ; Sun P; Lorenz RR; Lamarre E; Reddy SP; Kalvakolanu DV
Oncogene; 2014 Jun; 33(24):3195-204. PubMed ID: 23851499
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
